These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 20628843)
1. Suppression of human hepatoma (HepG2) cell growth by nuclear factor-kappaB/p65 specific siRNA. Wu W; Yao D; Wang Y; Qiu L; Sai W; Yang J; Yao N; Li S; Bian Y; Wang Z; Yao D Tumour Biol; 2010 Dec; 31(6):605-11. PubMed ID: 20628843 [TBL] [Abstract][Full Text] [Related]
2. Chemosensitization of HepG2 cells by suppression of NF-κB/p65 gene transcription with specific-siRNA. Shi Y; Wang SY; Yao M; Sai WL; Wu W; Yang JL; Cai Y; Zheng WJ; Yao DF World J Gastroenterol; 2015 Dec; 21(45):12814-21. PubMed ID: 26668505 [TBL] [Abstract][Full Text] [Related]
3. [Inhibitory effects of intervention of the TNFa/NF-kappaB signaling pathway activation on hepatoma cell proliferation]. Gu X; Yao M; Wang S; Shi Y; Dong Z; Qiu L; Yao D Zhonghua Gan Zang Bing Za Zhi; 2014 Jun; 22(6):434-9. PubMed ID: 25203707 [TBL] [Abstract][Full Text] [Related]
4. [Small interfering RNA-mediated nuclear factor-kappaB P65 suppression induces apoptosis of hepatic carcinoma SMMC-7721 cells]. Huang C; Yao JY; Li ZF; Liu LY; Ni L; Song TS Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1841-4. PubMed ID: 18158998 [TBL] [Abstract][Full Text] [Related]
5. [Role of inhibition of nuclear factor-kappa B gene transcription by specific miRNA in reversing multi-drug resistance of liver cancer]. Wang L; Cai Y; Shi Y; Yao M; Pan LH; Gu JJ; Yang XL; Wu W; Yao DF Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):493-499. PubMed ID: 27784426 [No Abstract] [Full Text] [Related]
6. Mechanistic study on growth suppression and apoptosis induction by targeting hepatoma-derived growth factor in human hepatocellular carcinoma HepG2 cells. Tsang TY; Tang WY; Tsang WP; Co NN; Kong SK; Kwok TT Cell Physiol Biochem; 2009; 24(3-4):253-62. PubMed ID: 19710540 [TBL] [Abstract][Full Text] [Related]
7. Reduced high-mobility group box 1 expression induced by RNA interference inhibits the bioactivity of hepatocellular carcinoma cell line HCCLM3. Jiang W; Wang Z; Li X; Li J; Huang Y; Fan X; Duan Y Dig Dis Sci; 2012 Jan; 57(1):92-8. PubMed ID: 22038506 [TBL] [Abstract][Full Text] [Related]
8. Exogenous hydrogen sulfide exerts proliferation/anti-apoptosis/angiogenesis/migration effects via amplifying the activation of NF-κB pathway in PLC/PRF/5 hepatoma cells. Zhen Y; Pan W; Hu F; Wu H; Feng J; Zhang Y; Chen J Int J Oncol; 2015 May; 46(5):2194-204. PubMed ID: 25738635 [TBL] [Abstract][Full Text] [Related]
9. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation. Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501 [TBL] [Abstract][Full Text] [Related]
10. Caspase-mediated p65 cleavage promotes TRAIL-induced apoptosis. Kim HS; Chang I; Kim JY; Choi KH; Lee MS Cancer Res; 2005 Jul; 65(14):6111-9. PubMed ID: 16024612 [TBL] [Abstract][Full Text] [Related]
11. Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death. Lluis JM; Buricchi F; Chiarugi P; Morales A; Fernandez-Checa JC Cancer Res; 2007 Aug; 67(15):7368-77. PubMed ID: 17671207 [TBL] [Abstract][Full Text] [Related]
12. Involvement of NF-kappaB activation in the apoptosis induced by extracellular adenosine in human hepatocellular carcinoma HepG2 cells. Wu LF; Li GP; Su JD; Pu ZJ; Feng JL; Ye YQ; Wei BL Biochem Cell Biol; 2010 Aug; 88(4):705-14. PubMed ID: 20651843 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of PTEN by HCV core protein through activating nuclear factor-κB. Zhang Y; Li RQ; Feng XD; Zhang YH; Wang L Int J Clin Exp Pathol; 2014; 7(11):7351-9. PubMed ID: 25550771 [TBL] [Abstract][Full Text] [Related]
14. Pim-2 activates API-5 to inhibit the apoptosis of hepatocellular carcinoma cells through NF-kappaB pathway. Ren K; Zhang W; Shi Y; Gong J Pathol Oncol Res; 2010 Jun; 16(2):229-37. PubMed ID: 19821157 [TBL] [Abstract][Full Text] [Related]
15. Suppression of toll-like receptor 2 expression inhibits the bioactivity of human hepatocellular carcinoma. Shi W; Su L; Li Q; Sun L; Lv J; Li J; Cheng B Tumour Biol; 2014 Oct; 35(10):9627-37. PubMed ID: 24964964 [TBL] [Abstract][Full Text] [Related]
16. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal. Zhang J; Zhang DL; Jiao XL; Dong Q Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232 [TBL] [Abstract][Full Text] [Related]
17. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation. Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108 [TBL] [Abstract][Full Text] [Related]
18. DHMEQ, a novel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells. Nishimura D; Ishikawa H; Matsumoto K; Shibata H; Motoyoshi Y; Fukuta M; Kawashimo H; Goto T; Taura N; Ichikawa T; Hamasaki K; Nakao K; Umezawa K; Eguchi K Int J Oncol; 2006 Sep; 29(3):713-9. PubMed ID: 16865289 [TBL] [Abstract][Full Text] [Related]
19. t-AUCB, an improved sEH inhibitor, suppresses human glioblastoma cell growth by activating NF-κB-p65. Li J; Liu H; Xing B; Yu Y; Wang H; Chen G; Gu B; Zhang G; Wei D; Gu P; Li M; Hu W J Neurooncol; 2012 Jul; 108(3):385-93. PubMed ID: 22382785 [TBL] [Abstract][Full Text] [Related]
20. [Effect of siRNA-mediated inhibition of nuclear transcription factor-kappa B on apoptosis of hepatocarcinoma cells]. Wang YL; Yao DF; Wu W; Sai WL; Qiu LW; Yang JL; Zhu JW Zhonghua Gan Zang Bing Za Zhi; 2010 Aug; 18(8):609-13. PubMed ID: 20825717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]